Neuropsychotoxicity of Abused Drugs: Molecular and Neural Mechanisms of Neuropsychotoxicity Induced by Methamphetamine, 3,4-Methylenedioxymethamphetamine (Ecstasy), and 5-Methoxy-N,N-diisopropyltryptamine (Foxy)
Psychostimulants including amphetamines and cocaine, opioids including morphine, and some recreational drugs share the ability to cause drug dependence and addiction. Although these drugs of abuse primarily act on distinct molecular targets, such as monoamine transporters or receptors, they finally...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2008-01-01
|
| Series: | Journal of Pharmacological Sciences |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319315294 |
| _version_ | 1818027414894149632 |
|---|---|
| author | Takayuki Nakagawa Shuji Kaneko |
| author_facet | Takayuki Nakagawa Shuji Kaneko |
| author_sort | Takayuki Nakagawa |
| collection | DOAJ |
| description | Psychostimulants including amphetamines and cocaine, opioids including morphine, and some recreational drugs share the ability to cause drug dependence and addiction. Although these drugs of abuse primarily act on distinct molecular targets, such as monoamine transporters or receptors, they finally converge to common neural pathways. Several lines of evidence suggest that their chronic treatment leads to the enhancement of the mesocorticolimbic dopaminergic neurons from the ventral tegmental area (VTA) to the nucleus accumbens (NAc) and the medial prefrontal cortex (mPFC) and leads to abnormal glutamatergic function from the mPFC to the NAc and VTA. The neural adaptation of dopaminergic-glutamatergic system is considered to be critically implicated in neuropsychotoxic effects of these drugs of abuse. In addition, recent studies suggest that the serotonergic neurons from the raphe nuclei to limbic areas modulate the mesocorticolimbic dopaminergic-glutamatergic system and participate in the neuropsychotoxicity. In this review, our recent in vitro studies on the molecular targets and neural adaptation of methamphetamine, 3,4-methylenedioxymethanphetamine (MDMA, “ecstasy”), and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DiPT, “foxy”) using Xenopus oocytes, organotypic slice cultures of the mesocorticolimbic dopaminergic-glutamatergic system, and the raphe serotonergic system are introduced. Keywords:: drugs of abuse, methamphetamine, 3,4-methylenedioxymethanphetamine (MDMA, “ecstasy”), 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DiPT, “foxy”), dopaminergic-glutamatergic system, serotonin transporter |
| first_indexed | 2024-12-10T04:47:32Z |
| format | Article |
| id | doaj.art-11739cf320394dd3a6dce3c98a6ba66b |
| institution | Directory Open Access Journal |
| issn | 1347-8613 |
| language | English |
| last_indexed | 2024-12-10T04:47:32Z |
| publishDate | 2008-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of Pharmacological Sciences |
| spelling | doaj.art-11739cf320394dd3a6dce3c98a6ba66b2022-12-22T02:01:42ZengElsevierJournal of Pharmacological Sciences1347-86132008-01-01106128Neuropsychotoxicity of Abused Drugs: Molecular and Neural Mechanisms of Neuropsychotoxicity Induced by Methamphetamine, 3,4-Methylenedioxymethamphetamine (Ecstasy), and 5-Methoxy-N,N-diisopropyltryptamine (Foxy)Takayuki Nakagawa0Shuji Kaneko1Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Shimoadachi-cyo, Yoshida, Sakyo-ku, Kyoto 606-8501, Japan; Corresponding author. tnakaga@pharm.kyoto-u.ac.jp Published online in J-STAGE: January 16, 2008Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, 46-29 Shimoadachi-cyo, Yoshida, Sakyo-ku, Kyoto 606-8501, JapanPsychostimulants including amphetamines and cocaine, opioids including morphine, and some recreational drugs share the ability to cause drug dependence and addiction. Although these drugs of abuse primarily act on distinct molecular targets, such as monoamine transporters or receptors, they finally converge to common neural pathways. Several lines of evidence suggest that their chronic treatment leads to the enhancement of the mesocorticolimbic dopaminergic neurons from the ventral tegmental area (VTA) to the nucleus accumbens (NAc) and the medial prefrontal cortex (mPFC) and leads to abnormal glutamatergic function from the mPFC to the NAc and VTA. The neural adaptation of dopaminergic-glutamatergic system is considered to be critically implicated in neuropsychotoxic effects of these drugs of abuse. In addition, recent studies suggest that the serotonergic neurons from the raphe nuclei to limbic areas modulate the mesocorticolimbic dopaminergic-glutamatergic system and participate in the neuropsychotoxicity. In this review, our recent in vitro studies on the molecular targets and neural adaptation of methamphetamine, 3,4-methylenedioxymethanphetamine (MDMA, “ecstasy”), and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DiPT, “foxy”) using Xenopus oocytes, organotypic slice cultures of the mesocorticolimbic dopaminergic-glutamatergic system, and the raphe serotonergic system are introduced. Keywords:: drugs of abuse, methamphetamine, 3,4-methylenedioxymethanphetamine (MDMA, “ecstasy”), 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DiPT, “foxy”), dopaminergic-glutamatergic system, serotonin transporterhttp://www.sciencedirect.com/science/article/pii/S1347861319315294 |
| spellingShingle | Takayuki Nakagawa Shuji Kaneko Neuropsychotoxicity of Abused Drugs: Molecular and Neural Mechanisms of Neuropsychotoxicity Induced by Methamphetamine, 3,4-Methylenedioxymethamphetamine (Ecstasy), and 5-Methoxy-N,N-diisopropyltryptamine (Foxy) Journal of Pharmacological Sciences |
| title | Neuropsychotoxicity of Abused Drugs: Molecular and Neural Mechanisms of Neuropsychotoxicity Induced by Methamphetamine, 3,4-Methylenedioxymethamphetamine (Ecstasy), and 5-Methoxy-N,N-diisopropyltryptamine (Foxy) |
| title_full | Neuropsychotoxicity of Abused Drugs: Molecular and Neural Mechanisms of Neuropsychotoxicity Induced by Methamphetamine, 3,4-Methylenedioxymethamphetamine (Ecstasy), and 5-Methoxy-N,N-diisopropyltryptamine (Foxy) |
| title_fullStr | Neuropsychotoxicity of Abused Drugs: Molecular and Neural Mechanisms of Neuropsychotoxicity Induced by Methamphetamine, 3,4-Methylenedioxymethamphetamine (Ecstasy), and 5-Methoxy-N,N-diisopropyltryptamine (Foxy) |
| title_full_unstemmed | Neuropsychotoxicity of Abused Drugs: Molecular and Neural Mechanisms of Neuropsychotoxicity Induced by Methamphetamine, 3,4-Methylenedioxymethamphetamine (Ecstasy), and 5-Methoxy-N,N-diisopropyltryptamine (Foxy) |
| title_short | Neuropsychotoxicity of Abused Drugs: Molecular and Neural Mechanisms of Neuropsychotoxicity Induced by Methamphetamine, 3,4-Methylenedioxymethamphetamine (Ecstasy), and 5-Methoxy-N,N-diisopropyltryptamine (Foxy) |
| title_sort | neuropsychotoxicity of abused drugs molecular and neural mechanisms of neuropsychotoxicity induced by methamphetamine 3 4 methylenedioxymethamphetamine ecstasy and 5 methoxy n n diisopropyltryptamine foxy |
| url | http://www.sciencedirect.com/science/article/pii/S1347861319315294 |
| work_keys_str_mv | AT takayukinakagawa neuropsychotoxicityofabuseddrugsmolecularandneuralmechanismsofneuropsychotoxicityinducedbymethamphetamine34methylenedioxymethamphetamineecstasyand5methoxynndiisopropyltryptaminefoxy AT shujikaneko neuropsychotoxicityofabuseddrugsmolecularandneuralmechanismsofneuropsychotoxicityinducedbymethamphetamine34methylenedioxymethamphetamineecstasyand5methoxynndiisopropyltryptaminefoxy |